Lymphotoxins from distinct types of lymphoid cells differentially contribute to neuroinflammation.
Cytokines
Experimental autoimmune encephalomyelitis
Lymphotoxin
Neuroimmunology
Neuroinflammation
Journal
European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201
Informations de publication
Date de publication:
29 Aug 2024
29 Aug 2024
Historique:
revised:
14
08
2024
received:
30
12
2023
accepted:
16
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
30
8
2024
Statut:
aheadofprint
Résumé
Lymphotoxin α and lymphotoxin β (LTs), TNF superfamily members, are expressed in either soluble (LTα
Identifiants
pubmed: 39210647
doi: 10.1002/eji.202350977
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2350977Subventions
Organisme : Russian Science Foundation
ID : 19-75-30032
Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : 075-15-2021-1067
Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : 075-15-2019-1660
Informations de copyright
© 2024 Wiley‐VCH GmbH.
Références
Selmaj, K., Raine, C. S., Cannella, B. and Brosnan, C. F., Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 1991. 87: 949–954.
Romme Christensen, J., Bornsen, L., Hesse, D., Krakauer, M., Sorensen, P. S., Sondergaard, H. B. and Sellebjerg, F., Cellular sources of dysregulated cytokines in relapsing‐remitting multiple sclerosis. J. Neuroinflammation 2012. 9: 215.
Fernandes Filho, J. A., Vedeler, C. A., Myhr, K. M., Nyland, H. and Pandey, J. P., TNF‐alpha and ‐beta gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF‐beta gene. Autoimmunity 2002. 35: 377–380.
Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J. and Clark, R. B., An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 1990. 172: 1193–1200.
Suen, W. E., Bergman, C. M., Hjelmstrom, P. and Ruddle, N. H., A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 1997. 186: 1233–1240.
Liepinsh, D. J., Grivennikov, S. I., Klarmann, K. D., Lagarkova, M. A., Drutskaya, M. S., Lockett, S. J., Tessarollo, L. et al., Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions. Mol. Cell. Biol. 2006. 26: 4214–4225.
Allie, N., Keeton, R., Court, N., Abel, B., Fick, L., Vasseur, V., Vacher, R. et al., Limited role for lymphotoxin alpha in the host immune response to Mycobacterium tuberculosis. J. Immunol. 2010. 185: 4292–4301.
Sean Riminton, D., Korner, H., Strickland, D. H., Lemckert, F. A., Pollard, J. D. and Sedgwick, J. D., Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin‐deficient, but not tumor necrosis factor‐deficient, mice. J. Exp. Med. 1998. 187: 1517–1528.
Kruglov, A. A., Lampropoulou, V., Fillatreau, S. and Nedospasov, S. A., Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells. J. Immunol. 2011. 187: 5660–5670.
De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C. et al., Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994. 264: 703–907.
Futterer, A., Mink, K., Luz, A., Kosco‐Vilbois, M. H. and Pfeffer, K., The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998. 9: 59–70.
Gommerman, J. L., Giza, K., Perper, S., Sizing, I., Ngam‐Ek, A., Nickerson‐Nutter, C. and Browning, J. L., A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. J. Clin. Invest. 2003. 112: 755–767.
Greter, M., Hofmann, J. and Becher, B., Neo‐lymphoid aggregates in the adult liver can initiate potent cell‐mediated immunity. PLoS Biol. 2009. 7: e1000109.
Tang, H., Zhu, M., Qiao, J. and Fu, Y. X., Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy. Cell Mol. Immunol. 2017. 14: 809–818.
Pikor, N. B., Astarita, J. L., Summers‐Deluca, L., Galicia, G., Qu, J., Ward, L. A., Armstrong, S. et al., Integration of Th17‐ and lymphotoxin‐derived signals initiates meningeal‐resident stromal cell remodeling to propagate neuroinflammation. Immunity 2015. 43: 1160–1173.
James Bates, R. E., Browne, E., Schalks, R., Jacobs, H., Tan, L., Parekh, P., Magliozzi, R. et al., Lymphotoxin‐alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration. Brain 2022. 145: 4287–4307.
Chiang, E. Y., Kolumam, G. A., Yu, X., Francesco, M., Ivelja, S., Peng, I., Gribling, P. et al., Targeted depletion of lymphotoxin‐alpha‐expressing TH1 and TH17 cells inhibits autoimmune disease. Nat. Med. 2009. 15: 766–773.
Kennedy, W. P., Simon, J. A., Offutt, C., Horn, P., Herman, A., Townsend, M. J., Tang, M. T. et al., Efficacy and safety of pateclizumab (anti‐lymphotoxin‐alpha) compared to adalimumab in rheumatoid arthritis: a head‐to‐head phase 2 randomized controlled study (The ALTARA Study). Arthritis Res. Ther. 2014. 16: 467.
St Clair, E. W., Baer, A. N., Wei, C., Noaiseh, G., Parke, A., Coca, A., Utset, T. O. et al., Clinical efficacy and safety of baminercept, a lymphotoxin beta receptor fusion protein, in primary Sjogren's syndrome: results from a phase II randomized, double‐blind, placebo‐controlled trial. Arthritis Rheumatol. 2018. 70: 1470–1480.
Diefenbach, A., Colonna, M. and Koyasu, S., Development, differentiation, and diversity of innate lymphoid cells. Immunity 2014. 41: 354–365.
Aparicio‐Domingo, P. and Cupedo, T., Rorgammat+ innate lymphoid cells in intestinal homeostasis and immunity. J. Innate. Immun. 2011. 3: 577–584.
Jager, A., Dardalhon, V., Sobel, R. A., Bettelli, E. and Kuchroo, V. K., Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 2009. 183: 7169–7177.
Grigg, J. B., Shanmugavadivu, A., Regen, T., Parkhurst, C. N., Ahmed, A., Joseph, A. M., Mazzucco, M. et al., Antigen‐presenting innate lymphoid cells orchestrate neuroinflammation. Nature 2021. 600: 707–712.
Kruglov, A. A., Grivennikov, S. I., Kuprash, D. V., Winsauer, C., Prepens, S., Seleznik, G. M., Eberl, G. et al., Nonredundant function of soluble LTalpha3 produced by innate lymphoid cells in intestinal homeostasis. Science 2013. 342: 1243–1246.
Batoulis, H., Recks, M. S., Holland, F. O., Thomalla, F., Williams, R. O. and Kuerten, S., Blockade of tumour necrosis factor‐alpha in experimental autoimmune encephalomyelitis reveals differential effects on the antigen‐specific immune response and central nervous system histopathology. Clin. Exp. Immunol. 2014. 175: 41–48.
Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., Pelczar, P., Clausen, B. E. et al., The Cytokine GM‐CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity. Immunity 2015. 43: 502–514.
Guendel, F., Kofoed‐Branzk, M., Gronke, K., Tizian, C., Witkowski, M., Cheng, H. W., Heinz, G. A. et al., Group 3 innate lymphoid cells program a distinct subset of IL‐22BP‐producing dendritic cells demarcating solitary intestinal lymphoid tissues. Immunity 2020. 53: 1015–1032 e8.
Vanderkerken, M., Baptista, A. P., De Giovanni, M., Fukuyama, S., Browaeys, R., Scott, C. L., Norris, P. S. et al., ILC3s control splenic cDC homeostasis via lymphotoxin signaling. J. Exp. Med. 2021. 218: e20190835.
Yang, B. H., Hagemann, S., Mamareli, P., Lauer, U., Hoffmann, U., Beckstette, M., Fohse, L. et al., Foxp3(+) T cells expressing RORgammat represent a stable regulatory T‐cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal. Immunol. 2016. 9: 444–457.
Summers‐DeLuca, L. E., McCarthy, D. D., Cosovic, B., Ward, L. A., Lo, C. C., Scheu, S., Pfeffer, K. et al., Expression of lymphotoxin‐alphabeta on antigen‐specific T cells is required for DC function. J. Exp. Med. 2007. 204: 1071–1081.
Chai, Q., Onder, L., Scandella, E., Gil‐Cruz, C., Perez‐Shibayama, C., Cupovic, J., Danuser, R. et al., Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity 2013. 38: 1013–1024.
Majumder, S., Amatya, N., Revu, S., Jawale, C. V., Wu, D., Rittenhouse, N., Menk, A. et al., IL‐17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival. Nat. Immunol. 2019. 20: 534–545.
Kim, D., Kim, M., Kim, T. W., Choe, Y. H., Noh, H. S., Jeon, H. M., Kim, H. et al., Lymph node fibroblastic reticular cells regulate differentiation and function of CD4 T cells via CD25. J. Exp. Med. 2022. 219: e20200795.
Liston, A., Kohler, R. E., Townley, S., Haylock‐Jacobs, S., Comerford, I., Caon, A. C., Webster, J. et al., Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. J. Immunol. 2009. 182: 3121–3130.
Yamazaki, T., Yang, X. O., Chung, Y., Fukunaga, A., Nurieva, R., Pappu, B., Martin‐Orozco, N. et al., CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 2008. 181: 8391–8401.
Bar‐Or, A., Fawaz, L., Fan, B., Darlington, P. J., Rieger, A., Ghorayeb, C., Calabresi, P. A. et al., Abnormal B‐cell cytokine responses a trigger of T‐cell‐mediated disease in MS? Ann. Neurol. 2010. 67: 452–461.
Tumanov, A., Kuprash, D., Lagarkova, M., Grivennikov, S., Abe, K., Shakhov, A., Drutskaya, L. et al., Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity 2002. 17: 239–250.
Pollok, K., Mothes, R., Ulbricht, C., Liebheit, A., Gerken, J. D., Uhlmann, S., Paul, F. et al., The chronically inflamed central nervous system provides niches for long‐lived plasma cells. Acta Neuropathol. Commun. 2017. 5: 88.
Galicia, G., Boulianne, B., Pikor, N., Martin, A. and Gommerman, J. L., Secondary B cell receptor diversification is necessary for T cell mediated neuro‐inflammation during experimental autoimmune encephalomyelitis. PLoS One 2013. 8: e61478.
Wang, A., Rojas, O., Lee, D. and Gommerman, J. L., Regulation of neuroinflammation by B cells and plasma cells. Immunol. Rev. 2021. 299: 45–60.
Picarella, D. E., Kratz, A., Li, C. B., Ruddle, N. H. and Flavell, R. A., Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas. Proc. Natl. Acad. Sci. U. S. A. 1992. 89: 10036–10040.
Matusevicius, D., Navikas, V., Soderstrom, M., Xiao, B. G., Haglund, M., Fredrikson, S. and Link, H., Multiple sclerosis: the proinflammatory cytokines lymphotoxin‐alpha and tumour necrosis factor‐alpha are upregulated in cerebrospinal fluid mononuclear cells. J. Neuroimmunol. 1996. 66: 115–123.
Hatfield, J. K. and Brown, M. A., Group 3 innate lymphoid cells accumulate and exhibit disease‐induced activation in the meninges in EAE. Cell. Immunol. 2015. 297: 69–79.
Columba‐Cabezas, S., Griguoli, M., Rosicarelli, B., Magliozzi, R., Ria, F., Serafini, B. and Aloisi, F., Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor‐Ig fusion protein. J. Neuroimmunol. 2006. 179: 76–86.
Lee, Y. K., Menezes, J. S., Umesaki, Y. and Mazmanian, S. K., Proinflammatory T‐cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 2011. 108: 4615–4622.
Kumar, P., Monin, L., Castillo, P., Elsegeiny, W., Horne, W., Eddens, T., Vikram, A. et al., Intestinal interleukin‐17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation. Immunity 2016. 44: 659–671.
Seregina, T. M., Mekshenkov, M. I., Turetskaya, R. L. and Nedospasov, S. A., An autocrine growth factor constitutively produced by a human lymphoblastoid B‐cell line is serologically related to lymphotoxin (TNF‐beta). Mol. Immunol. 1989. 26: 339–342.
Estrov, Z., Kurzrock, R., Pocsik, E., Pathak, S., Kantarjian, H. M., Zipf, T. F., Harris, D. et al., Lymphotoxin is an autocrine growth factor for Epstein‐Barr virus‐infected B cell lines. J. Exp. Med. 1993. 177: 763–774.
Rickert, R. C., Roes, J. and Rajewsky, K., B lymphocyte‐specific, Cre‐mediated mutagenesis in mice. Nucleic. Acids. Res. 1997. 25: 1317–1318.
Mufazalov, I. A. and Waisman, A., Isolation of central nervous system (CNS) infiltrating cells. Methods Mol. Biol. 2016. 1304: 73–79.
Fletcher, A. L., Malhotra, D., Acton, S. E., Lukacs‐Kornek, V., Bellemare‐Pelletier, A., Curry, M. et al., Reproducible isolation of lymph node stromal cells reveals site‐dependent differences in fibroblastic reticular cells. Front. Immunol. 2011. 2: 35.